Exchange: NASDAQ·Updated 05:04 AM EDT
NAUT logo

NAUT Nautilus Biotechnology Inc

$0.93
$0.036
(3.73%)
Pre-Market
Prev Close $0.966
EarningsOct 27
Mkt Cap$122.93M
Vol309.00

About NAUT

Nautilus Biotechnology, Inc. is a development stage life sciences company, which creates platform technology for quantifying and unlocking the complexity of the proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal M. Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.
31

Bearish Sentiment

How do you feel about NAUT?

Advertisement|Remove ads.